No significant association between proton pump inhibitor use and risk of
stroke after adjustment for lifestyle factors and indication.
Routine use of proton pump inhibitors (PPIs) was not associated with a significant increase in the risk of ischemic
stroke after adjustment for multiple risk stroke factors and PPI indications,...
Routine use of proton pump inhibitors (PPIs) was not associated with a significant increase in the risk of ischemic
stroke after adjustment for multiple risk stroke factors and PPI indications, according to results of a prospective, observational analysis published in Gastroenterology.
Not exact matches
After these
adjustments, the odds ratio of the composite endpoint of death, myocardial infarction or
stroke for bivalirudin versus heparin was not statistically significant (0.95); the odds ratio for acute stent thrombosis was 2.11 for bivalirudin versus heparin.
But
after adjustment for other
stroke risk factors, there was no association between the level of the neighborhood advantage and
stroke risk, suggesting that those living in more disadvantaged neighborhoods are more likely to develop risk factors including hypertension, diabetes and smoking.